155.46
price up icon1.83%   2.80
after-market Handel nachbörslich: 152.44 -3.02 -1.94%
loading

Finanzdaten der Charles River Laboratories International Inc-Aktie (CRL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-27 2025-09-27 2025-06-28 2025-03-29 2024-12-28
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
1.06%
994.23
1,004.85 1,032.13 984.17 1,002.55
Operating Expenses
46.68%
1,277.67
871.05 932.00 909.50 3,170.10
Benefits Costs and Expenses
4,114.89
- - - 3,956.88
Costs And Expenses
60.99%
1,402.33
871.05 932.00 909.50 1,304.47
Operating Income/Loss
311.84%
-283.44
133.80 100.13 74.67 -167.69
Income/Loss From Continuing Operations Before Tax
410.56%
-3,120.66
1,004.85 1,032.13 984.17 -2,954.33
Income Tax Expense/Benefit
156.28%
-17.81
31.64 18.73 10.10 -3.044
Income/Loss From Continuing Operations After Tax
597.32%
-276.29
55.56 52.69 25.88 -213.75
Net Income/Loss
597.32%
-276.29
55.56 52.69 25.88 -213.75
Preferred Stock Dividends And Other Adjustments
-
- - - 1.204
Attributable To Noncontrolling Interest
76.63%
0.265
1.134 0.367 0.409 0.748
Basic Average Shares
100.24%
-0.116
49.21 49.15 50.68 -0.081
Diluted Average Shares
100.61%
-0.302
49.43 49.32 50.85 -0.085
Basic Earnings Per Share
601.80%
-5.57
1.11 1.06 0.50 -4.19
Diluted Earnings Per Share
605.45%
-5.56
1.10 1.06 0.50 -4.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - 1.204
diagnostics_research LH
$263.80
price up icon 0.34%
diagnostics_research DGX
$199.70
price down icon 0.59%
diagnostics_research MTD
$1,173.74
price up icon 0.49%
$187.85
price down icon 1.29%
diagnostics_research IQV
$164.72
price up icon 1.10%
diagnostics_research WAT
$286.57
price up icon 1.15%
Kapitalisierung:     |  Volumen (24h):